BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37003979)

  • 1. ARNTL2 upregulation of ACOT7 promotes NSCLC cell proliferation through inhibition of apoptosis and ferroptosis.
    Wang T; Wang K; Zhu X; Chen N
    BMC Mol Cell Biol; 2023 Mar; 24(1):14. PubMed ID: 37003979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis.
    Tao R; Liu Z; Zhang Z; Zhang Z
    Anticancer Drugs; 2024 Jul; 35(6):483-491. PubMed ID: 38502867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
    Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C
    BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of ZNF488 supports pancreatic cancer cell proliferation and tumorigenesis through inhibition of ferroptosis via regulating SCD1-mediated unsaturated fatty acid metabolism.
    Xiao Q; Lan Z; Zhang S; Ren H; Wang S; Wang P; Feng L; Li D; Wang C; Bai X; Zhang J
    Biol Direct; 2023 Nov; 18(1):77. PubMed ID: 37986084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl-CoA Thioesterase 7 is Transcriptionally Activated by Krüppel-Like Factor 13 and Promotes the Progression of Hepatocellular Carcinoma.
    Xie X; Chen C; Feng S; Zuo S; Zhao X; Li H
    J Hepatocell Carcinoma; 2021; 8():1623-1641. PubMed ID: 34993160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF/BETA pathway and is regulated by miR-26a-5p.
    Wang Z; Liu T; Xue W; Fang Y; Chen X; Xu L; Zhang L; Guan K; Pan J; Zheng L; Qin G; Wang T
    Cell Death Dis; 2020 Aug; 11(8):692. PubMed ID: 32826856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 8. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between ACOT7 and LncRNA NMRAL2P via Methylation Regulates Gastric Cancer Progression.
    Feng H; Liu X
    Yonsei Med J; 2020 Jun; 61(6):471-481. PubMed ID: 32469171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
    Dong Z; Liu H; Zhao G
    Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
    [No Abstract]   [Full Text] [Related]  

  • 11. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma.
    Zhang H; Shan G; Jin X; Yu X; Bi G; Feng M; Wang H; Lin M; Zhan C; Wang Q; Li M
    Transl Oncol; 2022 Dec; 26():101562. PubMed ID: 36228410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX; Zhou KC; Cao Y
    Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXA1 prolongs S phase and promotes cancer progression in non-small cell lung cancer through upregulation of CDC5L and activation of the ERK1/2 and JAK2 pathways.
    Chen G; Wei RS; Ma J; Li XH; Feng L; Yu JR
    Kaohsiung J Med Sci; 2023 Nov; 39(11):1077-1086. PubMed ID: 37658700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PKA/CREB1 pathway confers sensitivity to ferroptosis in non-small cell lung cancer.
    Shan G; Bi G; Zhao G; Liang J; Bian Y; Zhang H; Jin X; Hu Z; Yao G; Fan H; Zhan C
    Respir Res; 2023 Nov; 24(1):277. PubMed ID: 37957645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer.
    Wang L; Kong W; Liu B; Zhang X
    Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of type 1 diabetes by upregulation of the circadian rhythm-related aryl hydrocarbon receptor nuclear translocator-like 2.
    He CX; Prevot N; Boitard C; Avner P; Rogner UC
    Immunogenetics; 2010 Sep; 62(9):585-92. PubMed ID: 20676886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.